Lygenesis

Pittsburgh, United States · Founded 2017 · $22.0M raised

Founded
2017
Business Model
B2B
Total Funding
$22.0M
Last Round
$19.0M Extension RoundOct 2023
Rounds
2

About

LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient's own lymph nodes into bioreactors capable of growing functioning ectopic organs. Its allogeneic cell therapies target some of the largest unmet needs in medicine, from Type 1 diabetes to end-stage liver and renal disease, upending the economics of organ transplantation since one donated liver can be used to treat dozens of patients via an outpatient endoscopic ultrasound procedure.

Summary

Lygenesis is a Biotech company based in Pittsburgh, United States, founded in 2017. It has raised $22.0M in total across 2 rounds, most recently a $19.0M Extension Round round in Oct 2023. Investors include Prime Movers Lab and Juvenescence.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A-2Oct 2023
$19.0M

Sign up to see all 2 rounds

Series A through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lygenesis on Indexed.vc
<a href="https://indexed.vc/companies/lygenesis"><img src="https://indexed.vc/api/badge/company/lygenesis" alt="Lygenesis on Indexed.vc" width="260" height="76" /></a>